[Medical treatment of heart failure in infants and young children].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001017:Aortic Coarctation / Q000188:drug therapy; D001919:Bradycardia / Q000139:chemically induced; D002740:Chlorothiazide / Q000008:administration & dosage; D004039:Diet, Sodium-Restricted; D004071:Digitalis Glycosides / Q000008:administration & dosage / Q000009:adverse effects; D004074:Digitoxin / Q000008:administration & dosage; D004077:Digoxin / Q000008:administration & dosage; D004361:Drug Tolerance; D004562:Electrocardiography; D004695:Endocardial Fibroelastosis / Q000188:drug therapy; D005665:Furosemide / Q000008:administration & dosage; D006327:Heart Block / Q000188:drug therapy; D006330:Heart Defects, Congenital / Q000150:complications / Q000188:drug therapy*; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D007799:Lanatosides / Q000008:administration & dosage; D009205:Myocarditis / Q000188:drug therapy; D009941:Organomercury Compounds / Q000008:administration & dosage; D010102:Oxygen Inhalation Therapy; D011189:Potassium Chloride / Q000008:administration & dosage; D011654:Pulmonary Edema / Q000188:drug therapy; D013610:Tachycardia / Q000188:drug therapy; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D014188:Transposition of Great Vessels / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D004071:Digitalis Glycosides; D007799:Lanatosides; D009941:Organomercury Compounds; D011189:Potassium Chloride; D004077:Digoxin; D002740:Chlorothiazide; D005665:Furosemide; D004074:Digitoxin
Traitement médical de l'insuffisance cardiaque du nourrisson et du petit enfant.